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ABSTRACT

In Vitro Testing and Evaluation of Intraaortic
and Extraaortic Balloon Counterpulsation Devices

by Joseph V. Izzo

The primary purpose of this project was to develop an
in vitro environment in which the intraaortic and extraaortic balloon pumps could be tested and evaluated. This
was done by modifying a mechanical heart simulator -- the
pulse duplicator system -- to accomodate both devices, and
developing a software system that could collect and process
the data relevant to the operation of the two balloons.
Both counterpulsation techniques were tested in the
pulse duplicator where the aortic pressure and flow data
were collected. The software system then processes the data
to calculate all of the parameters affected by counterpulsation.
While the results produced were not overly conclusive,
there were some trends which were noted. While neither
device demonstrated a more dominant effect on the mean
systolic pressure, the extraaortic balloon appeared to have
a more beneficial effect on the end diastolic pressure,
stroke volume, and cardiac output.
Since the pulse duplicator is a mechanical simulation
of the human cardiac cycle, it does have its limitations.

Future tests should be conducted with proper modifications
made to the pulse duplicator. More extensive testing could
reveal the extraaortic balloon pump to be a much more
effective device for counterpulsation than the intraaortic
balloon pump.

IN VITRO TESTING AND EVALUATION OF INTRAAORTIC
AND EXTRAAORTIC BALLOON COUNTERPULSATION DEVICES

by
Joseph V. Izzo

A Thesis
Submitted to the Faculty of
New Jersey Institute of Technology
in Partial Fulfillment of the Requirements for the Degree of
Master of Science in Biomedical Engineering
Biomedical Engineering Committee
January 1994

APPROVAL PAGE

IN VITRO TESTING AND EVALUATION OF INTRAAORTIC
AND EXTRAAORTIC BALLOON COUNTERPULSATION DEVICES

by Joseph V. Izzo

Dr. Clarence Mayott, Thesis Adviser (NJIT)
Assistant Professor of Mechanical Engineering, NJIT

Date

Dr. Shlomo Gabbay, Thesis Adviser (UMDNJ)
Associate Professor of Surgery, UMDNJ

Dte

Dr. David Kristol, Committee Member
Professor of Chemistry, Director and Graduate Advisor
of Biomedical Engineering, and Director of Biomedical
Engineering, NJIT

Date

BIOGRAPHICAL SKETCH

Author:

Joseph V. Izzo

Degree:

Master of Science in Biomedical Engineering

Date:

January 1994

Undergraduate and Graduate Education:
Master of Science in Biomedical Engineering,
New Jersey Institute of Technology, Newark, NJ, 1994
Bachelor of Engineering in Engineering Physics,
Stevens Institute of Technology, Hoboken, NJ, 1992
Major: Biomedical Engineering

iv

ACKNOWLEDGMENT

I would like to thank Dr. Gabbay of the University of
Medicine and Dentistry of New Jersey for his unending
guidance and motivation throughout this project. I also
wish to thank him for allowing me to use his facilities and
equipment in the Cardiothoracic Research Laboratory at
UMDNJ.
I would also like to express my gratitude to Dr. Mayott
of the New Jersey Institute of Technology for his continued
support and assistance in preparing this document.
My special thanks go out to Dr. Kristol of the New
Jersey Institute of Technology for serving as a committee
member for my thesis evaluation. I would also like to thank
him for his overall support during my graduate education.
And finally, a very special thanks to all of my friends
and family who encouraged me, and motivated me all of my
life.

v

TABLE OF CONTENTS

Page

Chapter
1 INTRODUCTION

1

2 BACKGROUND AND HISTORY

3

2.1 The Goal of Counterpulsation

3

2.2 Physical Basis for Counterpulsation

4

2.3 Timing of the Aortic Balloon Pump

6

2.4 Clinical Uses of Counterpulsation

8
8

2.4.1 Medical Indications
2.4.2 Mechanical Insufficiencies
2.5 History of Aortic Balloon Pumps

11

12
20

3 METHODS AND MATERIALS
3.1 The Pulse Duplicator System

20

3.2 The Computer and Data Acquisition Hardware

22

3.3 The Computer Software System

24

3.4 The IABP/EABP Control Unit

27

3.5 The Intraaortic and Extraaortic Balloons

30

3.6 Method of Testing

31
33

4 SUMMARY OF RESULTS
4.1 Mean Data

34

4.2 Parameters Versus Heart Rate

39

4.3 Parameters Versus Unassisted Cardiac Output

42

5 CONCLUSIONS

47

APPENDIX A Tables of Collected Data

51

APPENDIX B Plots of Data vs. Heart Rate

54

REFERENCES

59

vi

LIST OP TABLES

Table

Page

1 Mean Arterial Systolic Pressure vs. Heart Rate

40

2 Mean Arterial Diastolic Pressure vs. Heart Rate

40

3 End Diastolic Pressure vs. Heart Rate

40

4 Stroke Volume vs. Heart Rate

42

5 Cardiac Output vs. Heart Rate

42

6 Stroke Volume = 35 ml

51

7 Stroke Volume = 40 ml

52

8 Stroke Volume = 50 ml

53

vii

LIST OF FIGURES

Figure

Page

1 Diagram Showing Proper Positioning of the IABP

5

2 Diagram Showing Proper Positioning of the EABP

5

3 The Dynamic Aortic Patch

13

4 Diagram of the Single and Dual Chambered IABP's

14

5 Schematic Diagram of A Rigid Safety Chamber

15

6 The Auxiliary Ventricle

17

7 Diagram of the EABP II

19

8 Schematic of Pulse Duplicator System

21

9 Mean Pressure Data (All Points)

35

10 Mean Pressure Data (Failure Only)

35

11 Mean Cardiac Output Data

37

12 Mean Stroke Volume Data

39

13 Mean Arterial Systolic Pressure Versus
Unassisted Cardiac Output

43

14 Mean Arterial Diastolic Pressure Versus
Unasisted Cardiac Output

44

15 End Diastolic Pressure Versus
Unassisted Cardiac Output

45

16 Actual Cardiac Output Versus
Unassited Cardiac Output

46

17 Mean Arterial Systolic Pressure vs. Heart Rate

54

18 Mean Arterial Diastolic Pressure vs. Heart Rate

55

19 End Diastolic Pressure vs. Heart Rate

56

20 Stroke Volume vs. Heart Rate

57

21 Cardiac Output vs. Heart Rate

58

viii

CHAPTER 1

INTRODUCTION

Counterpulsation has been used for several years as a means
of aiding the failing heart in many patients. While
extensive research had been conducted in the 60's and early
70's to find the best device for counterpulsation, very
little research has been done in this area since that time.
Since research has been minimal, it is not surprising that
one method of counterpulsation has been used in clinical
situations more often than any other.
The most predominant form of counterpulsation device in
use today is the intraaortic balloon pump (IABP). While the
intraaortic balloon pump has been used for many years,
little has been done to increase its clinical effectiveness.
As such, the medical research community may soon begin to
reevaluate other methods of counterpulsation relative to the
intraaortic balloon. One of the purposes of this thesis
project has been to provide an in vitro environment where
devices of this type can be tested and evaluated. By
conducting in vitro testing of these devices, the researcher
can determine if in vivo testing is warranted before the
monetary investment in animal subjects, operating room time
and staff have been made.

1

2

Although one purpose of this project was to develop the
in vitro testing environment for various counterpulsation
devices, the main focus of this project was the evaluation
of the overall effectiveness of the intraaortic balloon pump
versus the extraaortic balloon pump (EABP). Both devices
were tested in a mechanical heart simulator -- the pulse
duplicator system -- while pressure and flow data were
collected and processed by a computer. The software system
isolates a single wave cycle and determines several
important pieces of information, including peak and mean
pressures, stroke volume, and cardiac output among others.
The software also generates a report containing all vital
information related to the test. This data can then be
compiled and analyzed accordingly.

CHAPTER 2

BACKGROUND AND HISTORY

2.1 The Goal of Counterpulsation
The basic purpose of counterpulsation is to assist the
failing heart. When the heart is in failure, that simply
means that the cardiac muscle must perform too much work for
the amount of oxygen it is receiving via the coronary blood
supply. There are several situations where these conditions
exist, and they will be discussed in a later section.
The description of heart failure stated above implies
that any method of assistance must perform two primary
functions. First, it must reduce the overall work done by
the heart. Secondly, it must increase coronary perfusion,
thereby increasing the flow of oxygen to the cardiac muscle.
The work performed by the myocardium can be defined by
the following equation:

In this equation, W is the myocardial work, V is the volume
of blood discharged during systole, P is the mean pressure
that the heart works against (i.e. mean arterial systolic
pressure), m is the mass of the ejected blood, and v is the
average velocity of the ejected blood (1). It is obvious
from this equation that when the mean pressure is reduced,
so is the total work done by the heart.
In order to meet the second requirement to assist the
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failing heart, the amount of blood circulating through the
coronary arteries must be increased. This could be done by
reducing the amount of blood flowing to the body, but that
would result in systemic ischemia and, perhaps, gangrene or
other serious complications. Instead, the coronary
perfusion must be increased by increasing the cardiac
output. In other words, the total volume of blood ejected
with each beat, or stroke volume (SV), must be increased.
How this is done will be discussed in the next section.

2.2

Physical Basis for Counterpulsation

Counterpulsation can be defined as a balloon generated
pressure pulse that occurs in a cycle counter to the normal
cardiac pulse (2). From this definition it can be inferred
that the peak pressure of the balloon generated wave will
occur during the diastole phase of the cardiac cycle.
Likewise, the minimum of the balloon pressure cycle will
occur at the high pressure phase of the cardiac cycle
(systole).
The counterpulsation wave is generated by a balloon of
a particular volume that is placed in some vicinity to the
aorta. In the case of the intraaortic balloon pump, the
device is placed inside the aorta in the descending arch
(Figure 1). The extraaortic balloon is connected to the
ascending arch via a cannula and is located outside of the
patient's aorta (Figure 2).

The wave is then generated by
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Figure 1 Diagram Showing Proper Positioning
of the IABP. (10)

Figure 2 Diagram Showing Proper Positioning
of the EABP. (9)
inflating and deflating the balloon devices at specific
times in the cardiac cycle.
By inflating the aortic balloon at the end of diastole,
just as the aortic valve closes, a volume of blood
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equivalent to the volume of the aortic balloon is displaced.
By pushing blood out of the volume occupied by the balloon
and into the aorta, the diastolic pressure within the aorta
is increased. As such, the blood is pushed into the
systemic and coronary circulations during the relaxation
phase of the heart (2).
At the beginning of the pumping phase of the heart, the
balloon should be deflated. When the volume previously
occupied by the balloon becomes vacant, it creates a small
vacuum in that area. This causes a sharp reduction in the
aortic pressure during the systolic phase. The net result
at this point is that the amount of muscular force needed to
pump blood out of the heart is reduced (2). This correlates
directly with a reduction in myocardial work.

2.3 Timing of the Aortic Balloon Pump
Obviously, the timing of the balloon inflation and deflation
points is extremely critical. There are four instances of
improper timing of the aortic balloon. These, of course,
are late inflation, early inflation, late deflation, and
early deflation (2,3). The drawbacks to each of these
scenarios will be discussed in this section.
The first situation to be discussed is late inflation.
If the balloon were inflated too late, much of the diastolic
pressure augmentation would be lost. This reduces the
pressure available to push blood into the coronary arteries.
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As such, the oxygen supply to the heart muscle is not
appreciably increased.
On the other hand, if the balloon were to be inflated
too early, this would cause a substantial increase in aortic
pressure before the aortic valve closes.

This scenario

would result in a decreased stroke volume since the aortic
valve would be forced to close before the ventricle could
eject its maximum volume.
While errors associated with inflation timing can diminish
the effectiveness of the aortic balloon pump, so can errors
in the deflation timing. For example, if the balloon were
to be deflated late (i.e. balloon is still inflated during
systole), the heart muscle would have to apply more pressure
to push its volume past balloon. This would greatly
increase the aortic systolic pressure which is contrary to
what counterpulsation is trying to accomplish. Likewise, if
the balloon is deflated too early, the vacuum caused by the
balloon deflation would occur while the ventricle is still
filling. This means that the aortic valve will open later
than if optimum timing were used. As such, there will be
little adjustment in the stroke volume of the heart, and
thus the oxygen supply to the heart will not increase
substantially.
Obviously, the proper timing of the aortic balloon
device is essential to its success in the clinical
situation. Any deviation from the proper timing of the
balloon can cause the assistance to the failing heart to be
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diminished, if not hindered. In either case, the benefits
to the patient are not what they should be. Therefore,
careful consideration must be used when adjusting the timing
of the aortic balloon pump.

2.4 Clinical Uses of Counterpulsation
As stated earlier, the primary purpose of counterpulsation
is to assist the failing heart. Failure is determined by
the imbalance of oxygen supplied to the heart and the oxygen
required by the heart in order to function. Therefore,
conditions where this imbalance is demonstrated are likely
to indicate the need for some sort of counterpulsative
assistance.
While the general need for counterpulsation is the same
in each case, the underlying cause of the problem can differ
from one condition to another. The increased oxygen demand
or diminished oxygen supply to the heart can be caused by a
number of different factors. Some may be medical in origin,
while others may result from mechanical defects (2). A few
of these situations will be mentioned in this section so as
to give an introduction into some areas where
counterpulsation would be used.
2.4.1 Medical Indications
Some of the medical problems which may require counterpulsative assistance are cardiogenic shock after a
myocardial infarction, septic shock, and unstable angina.
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In each case, it is a medical, not mechanical, defect that
is responsible for heart failure.
In the case of a myocardial infarction, a portion of
the cardiac muscle dies from oxygen starvation. The initial
destruction of the myocardium usual comes from a narrowing
or blockage of the cardiac circulation. Once a section of
the heart muscle dies, it can no longer contract. As a
result, the rest of the heart must increase its activity to
compensate for the part lost to the infarction. In essence,
the contractility of the heart is reduced.
Cardiogenic shock can result after a myocardial
infarction if the compensatory mechanisms of the body are
unable to make up for the loss of myocardial tissue.
Essentially, an avalanche effect occurs where more of the
heart muscle is damaged until patient death ultimately
occurs. If counterpulsation is employed at an early enough
stage, the avalanche effect can be avoided with the hope
that the bodies natural healing and compensatory mechanisms
would become effective.
Septic shock is similar to cardiogenic shock in that
the heart muscle does not get the oxygen supply that it
demands. However, septic shock is the result of an extreme
reduction in systemic pressure. This type of shock is
usually brought on by the presence of a toxin in the body
which attacks the smooth muscle surrounding the blood
vessels. The smooth muscle is paralyzed so that the blood
vessels are dilated to an extreme amount. The net result is
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to increase the volume in the body that the blood has to
occupy. By keeping the volume of the fluid the same, and
increasing the volume of the container, the systemic
pressure drops dramatically.
When the pressure of the system is reduced by a
substantial amount, that in turn causes a lack of coronary
circulation. When counterpulsation is used in this
scenario, the pressure in the aorta is increased to the
point where coronary perfusion, and thus coronary oxygen
supply, is increased. Again, this technique is used so that
the normal healing process of the body may deal with the
underlying medical problem accordingly.
The last medical indication for the use of counterpulsation that will be discussed is unstable angina. In a
large number of cases, angina will be a predecessor to a
myocardial infarction. In this case, the oxygen supply is
reduced to the point where the patient will feel discomfort
or pain, but the myocardium is not destroyed.
For most people, prescription drugs (such as
nitroglycerine) can help control angina, but in severe and
unstable cases more drastic techniques must be used. Counterpulsation can be very effective in relieving the
discomfort in some patients after only a few minutes of
pumping. The main advantage here is that it allows more
time for the physician to further analyze the patient's
condition.
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It should be reiterated here that these are only a few
of the medical indications for counterpulsation use. There
are several other conditions where oxygen supply to the
heart is reduced, or oxygen demand is increased to a point
where damage to the myocardium is the result. Again, this
section was meant only to illustrate how a variety of
different conditions can have a similar result that can be
countermanded by the use of counterpulsation.

2.4.2 Mechanical Insufficiencies
As mentioned above, not only medical problems can lead to
the insufficient oxygen delivery to the heart muscle. This
same condition can result from mechanical defects of the
heart as well. Two such conditions are valvular stenosis
(narrowing of the valve opening) and valvular insufficiency.
Valvular stenosis is described as the narrowing of the
valve opening. By reducing the valve orifice, the pressure
required to push blood through that opening is increased.
When the aortic valve is stenotic, the left ventricle must
contract harder and longer in order to eject the same volume
as a normal valve. Similarly, when the mitral valve is
stenotic, the volume entering the left ventricle is reduced,
and there is a pressure build up in the right ventricle and
pulmonary circuit. Both of these situations serve to
decrease the efficiency of the heart.
Counterpulsation is beneficial when valvular stenosis
exists because it reduces the pressure in the aorta that the
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ventricle is pumping against. As a result, the heart must
do less work to move a comparable volume of blood than
without the use of a balloon pump.
The other type of mechanical defect is mitral valvular
insufficiency. This situation results when a valve is
unable to completely seal off the atrium from the ventricle
when closed. Since the valve is not completely sealed, it
allows some volume of blood to be ejected in the opposite
direction of desired blood flow. Obviously, this decreases
the stroke volume of the heart.
By using counterpulsation in this instance, the
pressure of the aorta is greatly reduced, thereby increasing
the tendency for blood to flow towards it. This effect
serves to increase the amount of blood flowing forward,
despite the presence of mitral valvular insufficiency.

2.5 History of Aortic Balloon Pumps
The concept of counterpulsation is not a new idea. It was
initially introduced in an article by Clauss and Birtwell in
1961 (1). The device that they used consisted of an
artificial ventricle attached to an actuator that simulated
the volume changes of an actual ventricle. The artificial
ventricle was located exterior to the body and was attached
to the circulatory system via the femoral artery.
The first design for an aortic balloon device came in
1962. The first aortic balloon was an intraaortic type made
by Moulopoulos and Kolff (6). The balloon used in these
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cases was driven by a carbon dioxide pump and had only a
20 cc displacement volume. Most of the initial tests
performed by this group were in a mock circulatory system,
on dogs (deceased and living), and human cadavers. The
initial tests showed that cardiac output could be increased,
and that the end diastolic pressure (and thus, the cardiac
work) could be reduced with the use of the aortic balloon.
However, the later clinical tests were not as successful.
The intraaortic balloon pump still had several more years of
research and improvements to undergo.

Figure 3

The Dynamic Aortic Patch. (5)

In 1972, Kantrowitz proposed a device which was similar
to the intraaortic balloon pump in function, but was meant
to serve as a permanent assisting device (5). This device
was known as the dynamic aortic patch (Figure 3). It was
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basically constructed as an ellipsoidal balloon which gets
sewn into the wall of the descending aorta. As such, when
it is inflated, its volume expands from one side of the
aorta across to the other, rather than from the center of
the aorta outwards in all directions.
The first clinical test of the aortic patch on a human
showed that the device could be effective. Prior to this
test, many patients had died from emboli formation. In the
case reported by Kantrowitz in 1972, the dynamic aortic
patch resisted the formation of thromboemboli. Unfortunately, his patient died from a massive infection 96 days after
implantation of the aortic patch.

Figure 4

Diagram of the Single and Dual
Chambered IABP's. (7)

Also in 1972, the idea of a dual chambered balloon was
introduced (Figure 4). Bregman and Goetz designed a balloon

15

that had two sections (7). It had the long, cylindrical
segment which looked and functioned exactly like the
standard intraaortic balloon. However, attached to the
distal portion of the balloon was smaller balloon. The
smaller balloon had a larger diameter than the larger
balloon. The purpose was to inflate the smaller balloon
before the larger balloon. The smaller balloon would then
obstruct the flow of blood to the systemic circulation. As
such, most of the ejected blood volume from the heart would
be forced into the coronary circulation.
While the double chambered intraaortic balloon did not
become very popular, its design introduced the use of an
external safety chamber for the pumping mechanism. (Figure
5) The safety chamber is used to regulate the volume of gas
used to inflate the balloon with each cycle. It consists of
a rigid, plastic cylinder placed outside of the body.
Inside the rigid cylinder is a balloon which has the same
volume as the aortic balloon. The system is primed so that

Figure 5 Schematic Diagram of A Rigid
Safety Chamber. (7)
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when the aortic balloon is deflated, the safety balloon is
completely inflated.
By increasing the pressure in the safety chamber, the
balloon contained in the safety chamber is deflated. As a
result, the full volume of the safety balloon is pushed into
the aortic balloon. Conversely, by reducing the pressure in
the safety chamber, the safety balloon can draw gas out of
the aortic balloon, causing it to deflate.
The safety chamber has several beneficial properties.
First, it can regulate the amount of gas used to inflate the
aortic balloon. As such, the likelihood of over or under
inflation of the balloon is reduced.

Similarly, if the

aortic balloon should rupture for some reason, only a
limited volume of gas would be introduced into the patients
blood stream. Due to its beneficial design, the external
safety chamber is still used on many modern intraaortic
balloon control units.
In the early 1960's, several groups experimented with
devices that would deliver counterpulsation from a position
that was external to the aorta. The first of these devices
was described in 1963 by Nose and Kantrowitz (8). This
device served as an auxiliary left ventricle that was pumped
by an external controlling unit (Figure 6). The auxiliary
ventricle was connected to the ascending aorta on one side,
and the descending aorta on the other. In some cases, the
aorta was actually severed and sealed at the arch, just
proximal to the coronary arteries.
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Figure 6

The Auxiliary Ventricle. (8)

Over the next ten years, Kantrowitz and Nose continued
to research and develop the auxiliary ventricle. Many of
the clinical studies did not have promising results. Most
of the dogs that had the device implanted died within two
weeks. In the last clinical case, the patient only survived
for 12 days. The autopsy of this subject showed that there
had been extensive damage due to emboli formation.
It was not until several years later that anyone
produced positive results with an extraaortic counterpulsation device. In 1981, Gabbay proposed the device which
is currently called the extraaortic balloon pump (9).
It consisted of a rigid external housing with a balloon
inside. The balloon was inflated and deflated by applying
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an alternating positive/negative pressure to the balloon
inside the housing. When a negative pressure was applied
the balloon would inflate, thereby drawing blood out of the
aorta. The opposite would occur when a positive pressure
was applied.
This device differed from the auxiliary ventricle in
that it was open to the circulatory system at one end only.
As such, it was hoped that any emboli formation would be
limited to the inside of the device only. Should extensive
emboli formation take place, the device could be removed
(emboli and all) and replaced with a new one.
The early animal test results looked promising. In
most cases, it outperformed the intraaortic balloon in
systolic reduction, diastolic augmentation, and cardiac
output increase. Despite its efficiency, the extraaortic
balloon pump did not become overly popular because of the
methods and difficulties of inserting it via a very invasive
surgical procedure.
In 1983, Gabbay published another article dealing with
a redesigned extraaortic balloon that is commonly called the
EABP II (10). In this case, the balloon inside the rigid
shell was replaced with a diaphragm that was stretched
across the shell. In this position, the balloon (diaphragm)
was inflated from one side only. Through this construction,
the overall size of the extraaortic balloon pump was
decreased while its efficiency was increased. It was a
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balloon of this type that was tested, along with the
intraaortic balloon, for this project.

Figure 7

Diagram of the EABP II. (10)

As can be seen from this section, the overall idea of
counterpulsation to assist the failing heart has been around
for many years. Due to the initial success and easy use of
the intraaortic balloon pump, it gained favor in the medical
community. As such, most efforts to improve counterpulsation went into improving the intraaortic balloon rather than
developing the extraaortic balloon. One of the primary
purposes of this thesis is to help rejuvenate an interest in
the research and development of the extraaortic balloon
pump.

CHAPTER 3

METHODS AND MATERIALS

3.1 The Pulse Duplicator System
The pulse duplicator system (PDS) is a device used as a
mechanical simulator for the cardiac cycle. It was
developed over several years at the Cardiothoracic Research
Laboratory at the University of Medicine and Dentistry of
New Jersey (UMDNJ).

Over the years, many individuals have

contributed to the pulse duplicator project.
The primary function of the pulse duplicator system to
date has been the hemodynamic testing of prosthetic heart
valves. As such, it was designed so that pressure and flow
data could be measured at the mitral and aortic positions.
Since the balloon pumps are located in or near the aorta, it
was this position that was used in their testing.
The overall idea behind the construction and architecture of the pulse duplicator is relatively simple. It
consists of several plexiglass chambers and tubes which are
meant to represent the left atrium, left ventricle, and
aorta. Another chamber is used to represent the compliance
of the aorta and the systemic circulation. The peripheral
resistance of the system is generated by the serial combination of a filter and a column of water. Holes were drilled
in the plexiglass where pressure taps were desired. For
this project, one pressure tap was used and it was located
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slightly beyond the aortic valve. A schematic diagram
showing the general positions of each piece can be seen in
Figure 8.

Figure 8 Schematic of Pulse Duplicator System.
The pulse duplicator is also equipped with a piston
pump which is used to generate the pumping action of the
simulated heart. The stroke volume can be adjusted by
changing the length of the piston displacement. The pump
rate can be adjusted by changing the speed of the motor. By
doing so, the simulated heart rate can be set to the desired
level. Both of these factors were adjusted during the
testing procedures.
The pulse duplicator system is set up to collect
pressure and flow data via a computer. As such, the pulse
duplicator is equipped with two electromagnetic flow probes
that are permanently mounted on the device. One probe is
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used to measure the flow through the mitral valve, while the
other is arranged to measure flow through the aortic valve.
For the purpose of this project, the aortic flow probe was
used.
The pressure data for the aortic balloon testing is
collected from a pressure transducer located just beyond the
aortic valve. The pressure measured at this point is read
into the Kontron aortic balloon control unit (to be
discussed later) where it is used for the timing trigger of
the balloon. This information then gets passed to the
computer where it is stored on disk.

3.2 The Computer and Data Acquisition Hardware
The data collection system for this project consists of two
major components -- the computer, and the analog to digital
data acquisition card. The pulse duplicator system was
coupled with a computer many years ago to fascilitate data
collection and processing speed. Over the years, the system
has been upgraded to its present condition. Both of the
components that were used for this project will be discussed
in this section.
The computer used for the aortic balloon pump project,
as well as other projects in the Cardiothoracic Research
Laboratory, is based on an 80386 IBM compatible computer.
The computer is also equipped with a floating point math
coprocessor to speed up the data processing portion of the
software system.

The computer is attached to a Super VGA
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color monitor for a high resolution graphic representation
of wave forms, and a Hewlett Packard Laser Jet III printer
for hardcopy print outs of test results.
The computer is also equipped with a Keithley/MetraByte
DAS8/PGA data acquisition card (13). The analog to digital
converter on the card is a 12 bit, successive approximation
converter with an average conversion time of 15 milliseconds.

While only two of the channels were used for this

project, the presence of 8 channels allows for the easy
expansion of this project in the future.
The card also incorporates into its design three
programmable counters and a one megahertz crystal
oscillator. When these two components are coupled together,
they can generate a suitable square wave to trigger
interrupt driven data acquisition. As such, an equal time
interval between data points can be assured at all times.
Another convenient characteristic of the Keithley/MetraByte data acquisition board is that it comes with several
software library files which make initialization and data
collection with the board very easy. This eliminated the
need for tedious, and difficult software coding.
Overall, many of the components of the computer
hardware system were chosen because of their speed,
reliability, and ability to be upgraded. The system can
easily be repaired or upgraded by replacing only one portion
of the system. This eliminated the need to purchase a new
system whenever one component is to be changed.
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3.3 The Computer Software System
The computer software system for the aortic balloon testing
project was developed in the Cardiothoracic Research
Laboratory at UMDNJ specifically for use during this project
(18).

Under the supervision of Dr. Gabbay (UMDNJ) and Dr.

Mayott (NJIT), the system was designed to interface with the
existing pulse duplicator system, collect the relevant
pressure and flow data, and to process that information
accordingly. The program was also written in a modular type
of format so it could easily be debugged and modified.
While most of the program was written for this project,
some of the subroutines were written by Mr. John Andrews of
NJIT who wrote the software for the testing of heart valve
prosthesis in the pulse duplicator system. The routines
which were borrowed from Mr. Andrews' program were mainly
for cosmetic purposes. Since both systems now have the same
look and feel, a user who is familiar with one system may
use the other without much difficulty.
The software system was coded using Microsoft
QuickBASIC and the QuickBASIC library files that accompanied
the Keithley/MetraByte data acquisition card. The library
files made programming the data acquisition board very
simple. It allowed certain functions to be called by
setting the values of a few variables and executing a CALL
statement.
The workings of the program are very straight forward.
It firsts collects relevant data about the test to be
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performed, including the date, balloon size, and test
number. This information is stored so it can be recalled at
a later date.
The computer also prompts the user through a
calibration sequence. A water manometer is used in
calibrating the pressure transducer, while two reference
voltages are used to calibrate the electromagnetic flow
meter. In each case, a linear interpolation technique is
employed to determine the appropriate calibration factor for
each instrument. The data collected in this segment is
stored in a special calibration file to be referenced for
use in other portions of the program.
Much of the remainder of the program is dedicated to
the collection, storage, and processing of the test data.
Once the program is instructed to start collecting data, it
automatically collects 2.75 complete cycles of the pressure
and flow wave forms. It then isolates a single wave of
each, aligns them properly, and continues to process them.
The data for each wave form is also stored in its own data
file so it may be recalled at a later time.
There are several pieces of information which are
calculated by the software system. All of the parameters
which are either measured or calculated by the computer
program are:
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o
o
o
o
o
o
o
o
o

Peak Systolic Pressure (PSP)
Peak Diastolic Pressure (PDP)
End Diastolic Pressure (EDP)
Mean Arterial Systolic Pressure (MASP)
Mean Arterial Diastolic Pressure (MADP)
Mean Arterial Pressure (MAP)
Heart Rate (HR)
Stroke Volume (SV)
Cardiac Output (CO)

These are the predominant parameters that can be measured to
document the effectiveness of the aortic balloon pump.
Each of these parameters is found by either direct
measurement or by calculation. The peak systolic and
diastolic pressures are the values where the pressure curve
has zero slope. The end diastolic pressure is simply the
minimum value of the pressure curve. On the other hand, the
mean arterial pressures are calculated by integrating under
the appropriate portions of the pressure curve. These are
not arithmetic means, but area means (i.e. the total area
bounded by the mean pressure and the pressure wave form is
zero). In a similar fashion, the stroke volume is found by
integrating under the flow curve. The cardiac output is
simply the stroke volume multiplied by the heart rate. Once
all of these steps and calculations have been performed, the
computer moves on the next stage.
The final section of the program generates a report
which is printed out on the laser printer. The report
presents all of the data mentioned above, including the test
date, balloon type and size. The report also contains a
visual representation of the actual flow and pressure wave
forms. Since all the data for each test is stored at one
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point or another, a duplicate report can be generated at any
time by supplying only the test number that is to be
reviewed.
In general, the system was designed to be easy to use,
and also to allow for the recalling of the various data. As
such, the data is stored in two places (a print out, and on
the computer) and makes the data storage easier.

3.4 The IABP/EABP Control Unit
As mentioned in an earlier section, the timing of the aortic
balloon is extremely important. As such, it must be coupled
with a driving unit which can control the inflation and
deflation of the device. There are many different types of
machines that are available to perform this function. For
this project, a Kontron Air Ambulance Transport Intraaortic
Balloon Pump System was used (2).
The Kontron control unit is a very versatile device for
controlling the intraaortic balloon pump. It is equipped
with a safety chamber as described earlier to inflate and
deflate the aortic balloon. The balloon itself is filled
with helium gas because it is easier to move through small
tubes, and is less likely to form emboli that can block
capillaries. It contains a small helium tank for this
purpose.
The control unit is also equipped with a CRT screen to
show the user several different pieces of information. The
CRT constantly displays three wave forms -- the patient's
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ECG wave, either the arterial pressure wave or an auxiliary
pressure wave, and the balloon pressure wave. The control
unit also displays several other parameters, including the
peak diastolic pressure, the peak systolic pressure, the end
diastolic pressure, the mean arterial pressure and the heart
rate.
Surrounding the CRT screen are a set of "soft keys"
which are used to pull up menus and perform various
functions. The menus which can be selected are The
Operations Menu, the Calibration Menu, the Alarms Menu, and
the Recorder Menu. The Operational Menu allows the user to
set the balloon inflation volume, the pump ratio, and the
trigger pattern. From the Calibration Menu, the pressure
transducer is calibrated, and the display ranges can be set.
The Alarms Menu allows the user to disable any alarms that
may cause the system to shut down automatically. Finally,
the Recorder Menu is where the parameters for the optional
strip chart recorder are set, including which waves (up to
two) will be displayed, and how fast the recorder paper will
move. All of these functions are explained in more detail
in the operations manual for this particular device.
On the front panel of the control unit, there are also
a set of analog inputs and analog outputs. The inputs allow
signals to be entered from other devices, such as an
external ECG monitor, or external pressure signals. The
analog outputs allow the signals which are obtained by the
control unit to be output to another device. For this
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project, the arterial pressure wave was read by the control
unit's pressure transducer and is then sent to the computer
via these output plugs.
One of the reasons that this particular unit is so
versatile is because it can trigger the balloon inflation/
deflation from several different inputs including electrocardiogram (ECG), arterial pressure wave, or an internal
trigger source. The availability of several trigger sources
is very beneficial in a clinical situation. However, since
this project dealt with an in vitro testing environment,
only the arterial pressure wave could be used for triggering
the balloon operation.
While the control unit controls the timing of the
balloon inflation/deflation, it does not perform the timing
in an optimal fashion. Therefore, the control unit is
equipped with two controls knobs which allow the user to
adjust the balloon inflation and deflation timing. As such,
the operator can fine tune the balloon inflation and
deflation points.
Overall, the intraaortic balloon pump control unit,
manufactured by Kontron Instruments, is a typical example of
the various balloon pump control units that are commercially
available. Many of the features described above are also
present on devices manufactured by other medical device
companies.
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3.5 The Intraaortic and Extraaortic Balloons
The design of the intraaortic and extraaortic balloons are
relatively simple. This section will briefly describe the
each of these devices.
The first device that will be described is the intraaortic balloon. The actual balloon is a long, slender
cylinder of thin polyurethane. The balloon is placed so it
covers the last several inches of a semiflexible catheter.
The catheter is used to carry the inflating gas (helium)
from the control pump unit to the balloon. The covered
portion of the catheter contains several holes so the
inflation/deflation of the balloon is uniform, rather than
from one end to the other.
The intraaortic balloons can come in a number of
different volumes. For this project, a 40 cc balloon was
used. The dimensions of the balloon all depend on the
maximum volume of the balloon. The diameter is limited
since the balloon should not completely occlude the artery
when it is inflated. The balloon that was used for this
project had a length of approximately 26 centimeters and a
diameter of a little less than 1.5 centimeters.
The construction of the extraaortic balloon is quite
different than the intraaortic balloon.

The extraaortic

balloon which was tested for this project was the EABP II
design which was in the previous chapter.

It has a rigid,

outer shell made of polyurethane with the flexible diaphragm
stretched across the center of the shell. This balloon had
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a shell volume of 60 cc, but the diaphragm was shaped so it
could only displace 40 cc.
The extraaortic balloon has an advantage over the
intraaortic balloon when it comes to size limitations.
While the diameter of the intraaortic balloon should not he
equal to or greater than the diameter of the aorta, the size
and shape of the extraaortic device do not have such
limitations. Since the extraaortic balloon is placed
outside of the circulatory system, the only limitations
would be placed on the size of the catheter that was used.
As is described in this section, the design and
construction of both devices, while very different, are
relatively simple. For the most part, each device is just a
set of various plastic components that are assembled in the
required fashion.

3.6 Method of Testing
The testing procedure both of these devices was relatively
straight forward. The goal was to evaluate the intraaortic
balloon and the extraaortic balloon versus a no balloon
(control) situation. A protocol was devised to test both
devices at several pump rates and a variety of stroke
volumes. The object was to simulate failure in the system,
where failure is defined as a cardiac output below four
liters per minute. A summary of the testing procedure is as
follows:
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1) Test system with: No Balloon (Control Group)
Intraaortic Balloon Pump
Extraaortic Balloon Pump
2) Heart Rates:
(each device)
3) Stroke Volumes:
(each device)

75, 85, 95, 105, and 115
beats per minute
35, 40, and 50 ml per beat

This testing procedure resulted in a total of 45
individual tests being performed.

The software system

generated a report containing values for several parameters
after each test run.

The parameters which are the main

focus of this study are the mean arterial systolic pressure
(MASP), the mean arterial diastolic pressure (MADP), the
cardiac output (CO), and the end diastolic pressure (EDP).
A discussion of the data that was obtained comes in the next
chapter.

CHAPTER 4

SUMMARY OF RESULTS

There were four complete sets of data that were collected
during the course of this project.

Each data set consisted

of test runs at three different stroke volumes, and 5
different heart rates. One set of data was collected with
the intraaortic balloon pump and another set with the
extraaortic balloon pump. There were two complete sets of
data for the control (no balloon) situation -- one set for
each balloon pump.
The initial objective of this project was to evaluate
how the aortic balloon pumps would affect the failing heart.
For this project, "failure" was defined as having an unassisted cardiac output below four liters per minute. Due to
limitations of the pulse duplicator system, the number of
points that actually met this criterion was less than the
total number of points collected.
The data that was collected will be analyzed and
presented in a number of different ways in order to find any
trends that may exists. First, the average data for all
points will be described. This data will be compared to the
average data for points that correspond to failure only,
where failure is defined as a condition where the unassisted
cardiac output is below four liters per minute.
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Then, the
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major parameters will be shown versus other parameters such
as heart rate and unassisted cardiac output.
It was also mentioned in the previous chapter that
there were five parameters which were the primary focus of
this project. They are the mean arterial systolic pressure,
the mean arterial diastolic pressure, the end diastolic
pressure, the stroke volume, and the cardiac output. The
effect of the balloon pumps on these parameters as described
above will be discussed throughout the remainder of this
chapter.

4.1 Mean Data
First, the effects of counterpulsation on the three pressure
parameters will be discussed. It is expect that there will
be a reduction in both the mean arterial systolic pressure
and the end diastolic pressure. It is also expected that
there will be an increase in the mean arterial diastolic
pressure. In fact, all of these occurred during the in
vitro testing that was performed.
Figure 9 contains a graph showing the mean effects of
the counterpulsation devices on the three pressure
parameters. The information for this graph comes from the
arithmetic average of all data points that were collected.
Figure 10 shows the same parameters, but using only those
points that occurred during failure (unassisted cardiac
output less than 4 L/min) were used in its construction.

Figure 9

Figure 10

Mean Pressure Data (All Data)

Mean Pressure Data (Failure Only)
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mean arterial systolic or diastolic pressures. On the other
hand, it seems that the extraaortic balloon had an increased
effect on the end diastolic pressure when the heart was in
simulated failure.

Figure 11

Mean Cardiac Output Data

The effects of the counterpulsative devices on the
cardiac output will now be examined. Figure 11 shows the
effect on cardiac output for all data points and the data
points which correspond to failure only. Like before, these
points are the arithmetic average of the points that are
specified. From this figure, it is obvious to see that the
extraaortic balloon pump consistently provides a cardiac
output that is 1.2 L/min more than the intraaortic balloon,

38

and 3.2 L/min higher than the control situation. It should
also be noted that the mean data from the failure points is
consistently 0.7 L/min less than the data obtained from all
of the data points.
The information presented in Figure 11 illustrates two
noticeable trends.

First, cardiac output of the extraaortic

balloon pump shows a marked increase over the intraaortic
balloon pump. Secondly, it can be seen that the value of
the cardiac output is related to the level of failure that
is encountered. This second trend is not unexpected since
the definition of failure is based on a low value for the
cardiac output.

By eliminating points that were outside of

the failure limits, several of the points of higher cardiac
output were eliminated as well.
Lastly, the mean values of the stroke volume will be
discussed. Figure 12 contains this information in failure
only, and from all points obtained. As with the cardiac
output data, it should be noted that the extraaortic balloon
produces as larger increase in stroke volume (about 34 ml
above control) than the intraaortic balloon pump (around 22
ml above control). The net effect is a 12 milliliter per
beat advantage for the extraaortic balloon over the intraaortic balloon.
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Figure 12

Mean Stroke Volume Data

4.2 Parameters Versus Heart Rate
This section will present the same five parameters listed
above, but as a function of heart rate rather than the
overall mean data. By presenting the data in this format,
additional trends may become visible.
Table 1 contains the values of the mean systolic
pressure as related to heart rate. The information for the
mean arterial diastolic and end diastolic pressures can be
seen in Tables 2 and 3 respectively. A series of
corresponding graphs related to these tables can be seen in
Appendix B.

40
Table 1
Mean Arterial Systolic Pressure vs. Heart Rate
HR

Control
(mmHg)

EABP
(fig)

IABP
(fig)

75
85
95
105
115

45.4
48.8
50.0
47.6
48.8

35.2
37.5
40.4
40.6
43.2

37.9
34.6
38.1
39.7
42.0

Table 2
Mean Arterial Diastolic Pressure vs. Heart Rate
HR
75
85
95
105
115

Control
(mmHg)

EABP
(mmHg)

IABP
(mmHg)

33.2
36.8
38.4
38.9
39.7

46.6
49.2
45.8
42.9
42.8

48.9
49.3
50.1
50.9
50.6

Table 3
End Diastolic Pressure vs. Heat. Rate
HR
75
85
95
105
115

Control
(
g)

EABP
(mmHg)

IABP
(mmHg)

27.7
30.6
32.1
33.2
34.8

5.8
13.8
14.9
16.8
20.5

10.3
16.4
18.2
22.1
24.2

The data in these tables demonstrates that there is not
a substantial difference between the effect of the intraaortic balloon and the extraaortic balloon pump on the
systolic pressure. Both seem to reduce the systolic
pressure by a similar amount. However, there does seem to
be a trend where the mean arterial systolic pressure
increases as the heart rate increases.
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As for the effect of each device on the mean arterial
diastolic pressure, it appears that again, the intraaortic
balloon produces a higher mean diastolic pressure than the
extraaortic balloon pump, especially at higher heart rates.
The numbers show that the intraaortic balloon maintains an
average advantage of four millimeters of mercury over the
extraaortic balloon. Also, it seems that the mean diastolic
pressure drops down as heart rate increases for the
extraaortic balloon while the pressure remains relatively
constant for the intraaortic balloon.
It can also be seen from Table 3 that the extraaortic
balloon pump still shows a larger end diastolic pressure
reduction than the intraaortic balloon pump. There also
seems to be a trend where the end diastolic pressure
increases with an increase in heart rate. This information
is not remarkably different from the mean data that was
presented in the previous section.
Table 4 contains the stroke volume data related to
heart rate, while Table 5 shows the cardiac output data.
The results here are very similar to those indicated by the
mean data that was discussed above. It is easy to see from
these tables that the extraaortic balloon pump increases the
stroke volume by an average of 12 milliliters above that of
the intraaortic balloon.

Similarly, the extraaortic balloon

increases the cardiac output by one liter per minute above
the intraaortic balloon. In both cases, this is a
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substantial advantage of the extraaortic balloon over the
intraaortic balloon pump.
Table 4
Stoke Volume vs. Heart Rate
HR
75
85
95
105
115

Control
(ml)
41.1
43.0
44.2
40.4
43.0

EABP
(ml)

IABP
(ml)

83.1
73.9
75.6
75.9
67.8

61.8
63.2
68.2
59.0
64.7

Table 5
Cardiac Output vs. Heart Rate
HR
75
85
95
105
115

Control
(L/min)
3.1
3.7
4.2
4.3
4.9

EABP
(L/min)

IABP
(L/min)

6.5
6.4
7.2
8.0
7.8

4.6
5.4
6.5
6.2
7.4

4.3 Parameters Versus Unassisted Cardiac Output
As was seen in Section 4.1, some parameters seemed to be
more profoundly effected if only those points that were
considered failure were used in their evaluation. Since the
ultimate goal of this project was to see how the counterpulsation devices performed under simulated failure conditions,
only these points will be presented in this section.
Figures 13, 14, and 15 all show plots of the three
measured pressures versus the unassisted cardiac output of
the heart. Since the definition of failure used for this
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project was based only on the unassisted cardiac output,
these graphs show how the system pressures were effected by
the level of failure that was experienced by the system.

Figure 13

Mean Arterial Systolic Pressure
Versus Unassisted Cardiac Output

This information indicates that neither device produces
a more beneficial effect on the mean arterial systolic
pressure. In fact, these graphs shown them to be almost
identical for each cardiac output.
However, the graph showing the mean arterial diastolic
pressure shows an interesting trend. While the intraaortic
balloon shows a relatively constant pressure, the extraaortic balloon seems to cause an increase in diastolic pressure
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Figure 14 Mean Arterial Diastolic Pressure
Versus Unassisted Cardiac Output
as the cardiac output decreases. This leads to the notion
that the extraaortic balloon may produce a higher mean
diastolic pressure, and thus coronary perfusion pressure, as
the level of failure increases.
A look at the plot for end diastolic pressure does not
seem to indicate any new trends. The end diastolic pressure
produced by the extraaortic balloon is substantially lower
than the pressure produced by the intraaortic balloon. The
plot also shows that the extraaortic balloon seems to have a
more prominent effect on this parameter when the level of
failure increases.
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Figure 15 End Diastolic Pressure
Versus Unassisted Cardiac Output
The final parameter that will be examined in this
section is the measured cardiac output with respect to the
unassisted cardiac output. This information can be seen in
Figure 16. It should be noted that the extraaortic balloon
produces a cardiac output that is either the same as, or
higher than the cardiac output generated when the
intraaortic balloon pump is used. However, the points from
the extraaortic balloon are quite scattered on the graph.
Because of this scattering of data points, it is very
difficult to interpret any trends that may exist on this
graph. As a result, further testing would have to be done
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Figure 16 Actual Cardiac Output Versus
Unassisted Cardiac Output
in order to gain any other conclusive evidence from this
relationship.

CHAPTER 5

CONCLUSIONS

At this point, it should be reiterated that one of the
primary purposes behind this project was to demonstrate that
research behind alternative counterpulsation devices -namely the extraaortic balloon pump -- is an avenue that
should not be abandoned. While the intraaortic balloon pump
has become the standard for counterpulsation, it has been
shown that the intraaortic and extraaortic balloons effect
certain physiological parameters to different degrees.
One of the goals of counterpulsation is to cause a
reduction in the arterial systolic pressure. The test
results from this project consistently showed that there is
very little difference between the intraaortic balloon and
extraaortic balloon when it comes to the reduction of the
systolic pressure. Both devices appeared to have generated
comparable systolic reduction in all levels of failure.
It was noted in the previous chapter that the
intraaortic balloon tended to produce a higher mean arterial
diastolic pressure than the extraaortic balloon pump.
However, since this is an in vitro study, these numbers may
be misleading. The function and position of the intraaortic
balloon is such that it will cause blood to flow both
forward, through the systemic circulation, and backwards,
through the coronary circulation. The pulse duplicator
47
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system is not equipped with a coronary circulation circuit
upstream from the balloon placement. This means that the
blood flow in the reverse direction has no path to follow.
As such, there would be a slight build up in pressure behind
the intraaortic balloon in the in vitro system that probably
would not be seen in a physiological system.
Another parameter that is effected by the balloons is
the end diastolic pressure. The data that was collected
indicated that the extraaortic balloon caused a larger
reduction in end diastolic pressure than the intraaortic
balloon. Physiologically, this means that the heart would
experience a shorter isovolumetric contraction phase. In
the testing environment, it would indicate that the piston
pump had to do less work.

The pulse duplicator pump

operates at a constant velocity and constant stroke volume.
By lowering the end diastolic pressure in the aorta, the
piston pump experiences a lower resistance pressure through
its displacement. Therefore, it would seem likely that the
larger pressure reduction seen in the in vitro system might
be observed in an in vivo system as well.
Finally, it should be noted that the extraaortic
balloon pump of the same displacement volume produced a much
higher cardiac output and stroke volume than the intraaortic
balloon. This indicates that the extraaortic balloon has a
certain advantage over the intraaortic balloon in this area.
By increasing the fluid ejected from the heart, the
oxygenated blood supply to the myocardium is being increased
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as well. This is a highly advantageous and desirable
situation in the case of a failing heart.
From the data obtained in this study, it cannot be
decided conclusively which device is best for supplying
counterpulsation. Neither has the advantage in mean
systolic reduction. However, the intraaortic balloon
appears to have the advantage in diastolic pressure
augmentation, while the extraaortic balloon seems to be
superior when comparing the end diastolic pressure and the
fluid output of the heart.
Although this study has shown neither device to be
exceptionally superior over the other, it would seem to
indicate that further study is required. Future studies may
include a model of the coronary circulation to see how the
pressure and flow data will be affected. Also, the piston
pump could be modified to accommodate even lower stroke
volumes so that tests could be conducted in more severe
levels of failure. Another way of improving the testing
procedure would be to use a flexible piece of tubing for the
aorta. Since the aorta for this project was made of rigid
plexiglass, any localized effects of its compliance was
lost. Of course, in vivo studies should be conducted in the
near future as well.
While there are still many areas of study that should
be addressed in the future, this work indicates that further
studies are warranted. Scientists and engineers involved in
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the medical field should always look to improve the quality
and efficiency of existing techniques. The intraaortic
balloon pump has shown very little increase in efficiency
and effectiveness over the past several years. The
extraaortic balloon may very well be the next level in
counterpulsative technology.

APPENDIX A
Tables of Collected Data

Table 6

Stroke Volume = 35 ml

Data
Group

CO
SV
EDP
MADP
HR
MASP
(bt/min) (mmHg) (mmHg) (mmHg) (ml/bt) (L/min)

Control
(EABP)

73.9
84.5
96.2
107.1
117.2

46.8
46.7
52.4
41.9
48.1

29.3
33.8
35.3
35.4
40.5

26.1
26.0
27.9
28.9
35.0

35.7
38.6
37.2
31.9
38.4

2.6
3.3
3.6
3.4
4.5

Control
(IABP)

78.1
87.0
94.6
104.9
117.2

43.7
44.8
49.7
49.7
50.3

33.8
35.6
41.0
40.8
40.9

28.8
30.1
35.8
36.7
37.8

32.2
34.2
30.7
32.2
32.9

2.5
3.0
2.8
3.4
3.9

EABP

75.4
86.7
96.8
107.5
114.9

33.5
31.6
35.3
37.6
42.9

49.5
49.0
43.0
39.2
42.7

5.8
4.5
9.1
12.0
17.0

66.2
79.7
70.7
55.2
57.6

5.0
6.9
6.8
5.9
6.6

IABP

73.9
85.0
96.8
104.5
114.1

33.5
31.6
37.6
39.5
44.4

49.5
49.2
50.9
49.9
49.4

10.8
19.1
24.9
26.8
28.4

66.2
68.7
60.4
49.0
65.9

5.0
5.8
5.8
5.1
7.5
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Table 7

Stroke Volume = 40 ml

Data
Group

MADP
HR
MASP
EDP
SV
CO
(bt/min) (mmHg) (mmHg) (mmHg) (ml/bt) (L/min)

Control 1
(EABP)

75.6
85.5
95.8
105.6
112.8

42.3
51.3
45.5
43.2
44.0

31.9
40.0
38.7
35.6
35.2

26.1
34.7
31.2
28.9
29.3

39.4
42.5
45.4
35.6
40.0

3.0
3.6
4.4
3.8
4.5

Control 2
(IABP)

76.3
85.7
94.9
105.6
115.4

47.8
48.0
49.8
47.9
47.3

35.9
37.3
37.7
37.2
36.6

30.5
31.3
31.8
32.9
33.1

39.6
39.3
43.0
39.2
47.9

3.0
3.4
4.1
4.1
5.5

EABP

77.5
88.2
94.6
104.5
112.8

34.6
37.9
40.2
38.0
40.1

45.1
50.1
45.0
41.2
39.0

5.9
20.6
12.1
10.9
15.1

86.7
57.7
65.0
77.1
64.3

6.7
5.1
6.2
8.1
7.3

IABP

75.6
85.7
97.1
106.0
114.1

38.0
33.9
37.6
36.7
36.2

48.9
50.1
50.8
48.6
48.8

11.7
17.2
14.8
15.9
18.3

48.0
65.9
61.7
57.9
64.2

3.6
5.6
6.0
6.1
7.3
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Table 8

Stroke Volume = 50 ml
SV
(ml/bt)

CO
(L/min)

HR
(bt/min)

MASP
(mmHg)

MADP
(mmHg)

EDP
(mmHg)

Control 1
(EABP)

78.1
87.2
95.5
106.0
115.4

44.6
53.1
51.7
51.0
50.6

32.9
38.7
41.9
42.8
42.4

26.1
33.3
35.6
36.0
36.5

49.3
52.2
56.5
49.6
51.7

3.9
4.6
5.4
5.3
6.0

Control 2
(IABP)

75.2
86.5
95.5
106.8
114.5

47.4
48.7
51.2
52.2
52.6

35.3
35.4
35.7
42.0
42.7

28.7
28.4
30.2
36.1
37.6

50.2
51.7
51.6
54.1
47.0

3.8
4.5
4.9
5.8
5.4

EABP

80.4
86.5
95.5
105.3
115.8

37.6
43.1
45.8
46.2
46.5

45.2
50.6
49.3
48.4
46.7

5.6
16.3
23.4
27.6
29.6

96.5
84.3
91.0
95.3
81.5

7.8
7.3
8.7
10.0
9.4

IABP

74.8
87.5
94.9
105.6
114.9

42.1
38.2
39.0
42.9
45.4

48.3
48.7
48.6
54.3
53.6

8.4
13.0
14.8
23.5
25.9

71.1
54.9
82.6
70.1
64.0

5.3
4.8
7.8
7.4
7.4

Data
Group

APPENDIX B
Plots of Data vs. Heart Rate

Figure 17

Mean Arterial Systolic Pressure
vs. Heart Rate
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Figure 18

Mean Arterial Diastolic Pressure
vs. Heart Rate
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Figure 19 End Diastolic Pressure
vs. Heart Rate
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Figure 20

Stroke Volume vs. Heart Rate
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Figure 21

Cardiac Output vs. Heart Rate
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